Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Asian OTC markets well-suited for local alliances -- consultant at NDMA annual meeting.

This article was originally published in The Tan Sheet

Executive Summary

STRATEGIC PARTNERSHIPS WITH LOCAL ASIAN OTC COMPANIES should be considered by Western pharmaceutical firms in lieu of acquisitions, Barri Blauvelt, CEO and group president of global management and business development firm Innovara, recommended at the Nonprescription Drug Manufacturers Association annual meeting May 20 in Colorado Springs. Claiming that "few outright acquisitions" of Asian self-medication firms are successful, Blauvelt suggested that alliances allow Western companies to avoid many of the pitfalls associated with the local traits of Asian markets.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS085434

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel